Austin Commercial Boosts Data Power With Versatile Partnership
Texas construction giant introduces AI-captured data from their sites to improve execution and job site…
Texas construction giant introduces AI-captured data from their sites to improve execution and job site…
44% say their interest in shopping sustainably has increased since the start of the pandemic…
CRN’s list is a resource for IT solution providers looking for industry-leading on-premises or cloud…
2-day interactive event brings research and network professionals together to share insights on network measurement,…
VeriSIM to share NIH Small Business Innovation Research (SBIR) grant to accelerate AI-driven drug discovery…
Bain brings more than 18 years of experience leading IT security organizations to Finite State,…
SAN DIEGO–(BUSINESS WIRE)–$DFCO #BoardofDirectors—Dalrada Corporation (OTCQB: DFCO, “Dalrada”) would like to thank its investors and…
LONDON, UK – Apr 19th, 2022 – MYCOM OSI, a leading independent provider of Assurance,…
Advanced first-in-class, one-day oral antifungal treatment, BREXAFEMME is now covered for approximately 55 percent of…
CAMBRIDGE, Mass., April 19, 2022 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
Summary: AXIM places strategic focus on commercializing FDA-cleared Dry Eye Disease (DED) diagnostic system Plans…
WALTHAM, Mass., April 19, 2022 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (“CinCor”) today announced its participation…
SOMERVILLE, Mass., April 19, 2022 (GLOBE NEWSWIRE) — Finch Therapeutics Group, Inc. (“Finch” or “Finch…
Dr. El-Gabry’s extensive leadership experience will be critical to accelerating Akoya’s groundbreaking spatial biomarker research…
Expects to Report Results of Independent Data Monitoring Committee (IDMC) Mandated Interim Safety Reviews and…
Accomplished business executive and attorney with diverse industry experience including over 20 years in life…
Biotech executive with robust experience in financial and corporate strategy and operational excellence will strengthen…
– Strengthens intellectual property portfolio for macimorelin and the commercial product Ghryvelin®/ Macrilen™in Europe as…
BOTHELL, Wash., April 19, 2022 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that…
MORRISVILLE, N.C., April 19, 2022 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated…